Prospective trial to investigate the nature of white opaque substance in colonic epithelial neoplasia as visualized by magnifying endoscopy with narrow-band imaging.
Not Applicable
- Conditions
- Colonic epithelial neoplasia
- Registration Number
- JPRN-UMIN000011220
- Lead Sponsor
- Fukuoka University Central Research Institute for Endoscopy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
Not provided
Exclusion Criteria
1. The neoplasias with erosion, ulceration or bleeding which disturb the endoscopic observation of surface morphology 2. The patients with serious underlying disorders 3. The patients with past history of colectomy 4. The patients that were determined to be inappropriate to participate in the study by the investigators
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To investigate whether or not the presence of WOS within the superficial part of the colonic neoplasia is correlated with the presence of lipid droplets in the histological specimen.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular composition of white opaque substance (WOS) in colonic epithelial neoplasia is identified via ME-NBI?
How does ME-NBI detection of WOS in colonic neoplasia compare to conventional endoscopy in early diagnosis accuracy?
Which histological biomarkers correlate with WOS presence in colonic epithelial neoplasia using ME-NBI?
What are the adverse events associated with ME-NBI in colonic epithelial neoplasia diagnosis?
Are there alternative endoscopic imaging techniques to ME-NBI for analyzing WOS in colonic neoplasia?